Evofem is a biopharmaceutical company that offers women reproductive and contraceptive care products.
Evofem is a biopharmaceutical company that offers women reproductive and contraceptive care products. The company's first commercial product, Phexxi®, is the first and only hormone-free, prescription vaginal gel approved in the United States to prevent pregnancy.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Feb 12, 2014 | Series C | $8M | 1 | — | — | Detail |
Dec 19, 2012 | Series C | $20.60M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
|
— | Series C |
![]() |
— | Series C |